Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Fosigotifator by Calico Life Sciences for Unspecified Central Nervous System Disorders: Likelihood of Approval
Fosigotifator is under clinical development by Calico Life Sciences and currently in Phase II for Unspecified Central Nervous System Disorders....
Data Insights
Fosigotifator by Calico Life Sciences for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Fosigotifator is under clinical development by Calico Life Sciences and currently in Phase III for Amyotrophic Lateral Sclerosis. According to...